Compounds > magnolol
Page last updated: 2024-08-25

magnolol and Triple Negative Breast Neoplasms

magnolol has been researched along with Triple Negative Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Huang, L; Li, L; Liu, H; Liu, M; Ma, G; Sun, C; Sun, S; Wang, L; Wang, X; Wang, Y; Xu, H; Zhang, L; Zheng, J1
Dai, YQ; Li, BH; Li, HM; Ma, H; Sun, XL; Wu, CZ; Zhang, CH; Zhu, ML1

Other Studies

2 other study(ies) available for magnolol and Triple Negative Breast Neoplasms

ArticleYear
Magnolol-loaded cholesteryl biguanide conjugate hydrochloride nanoparticles for triple-negative breast cancer therapy.
    International journal of pharmaceutics, 2022, Mar-05, Volume: 615

    Topics: Animals; Biguanides; Biphenyl Compounds; Cell Line, Tumor; Drug Carriers; Humans; Lignans; Mice; Nanoparticles; Polyethylene Glycols; Triple Negative Breast Neoplasms

2022
Semi-Synthesis and In Vitro Anti-Cancer Evaluation of Magnolol Derivatives.
    Molecules (Basel, Switzerland), 2021, Jul-15, Volume: 26, Issue:14

    Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Lignans; Neoplasm Invasiveness; Triple Negative Breast Neoplasms

2021